ICICI Prudential Bharat Consumption Fund - Series 3 - Growth - Direct Plan

Other Plans and Options
  • (-0.47%)Nav, as on 22-10-2021

  • Previous Nav

  • Net Change on 22-10-2021

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the Scheme is to provide capital appreciation by investing predominantly in equity and equity related instruments of sectors that could benefit from growth in consumption and related activities.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY CONSUMPTION -3.02 10.41 41.43 16.26 12.84 13.18

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Mirae Asset Great Consumer Fund - Direct Plan - Growth Jan 01, 2013 58.69 23.09 19.38 0.55 1,552.18
Tata India Consumer Fund-Direct Plan-Growth Dec 28, 2015 51.54 19.05 20.02 0.88 1,352.34
ICICI Prudential FMCG Fund - Direct Plan - Growth Jan 01, 2013 43.10 14.55 14.28 1.63 849.98
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH Jan 01, 2013 72.40 18.59 16.91 1.42 808.69
Aditya Birla Sun Life Manufacturing Equity Fund - Direct Plan - Growth Feb 03, 2015 46.35 17.88 11.91 1.79 681.57

Fund Holdings as on 30-September-2021

  • TREPS

  • Titan Company Ltd.

  • Britannia Industries Ltd.

  • Net Current Assets

  • Alkem Laboratories Ltd.

  • Marico Ltd.

  • Asian Paints Ltd.

  • Motherson Sumi Systems Ltd.

  • Gland Pharma Ltd.

  • Maruti Suzuki India Ltd.

  • Hindustan Unilever Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Aditya Birla Fashion and Retail Ltd.

  • Nestle India Ltd.

  • 182 Days Treasury Bills

  • Dr. Reddy's Laboratories Ltd.

  • Inox Leisure Ltd.

  • Minda Industries Ltd.

  • IPCA Laboratories Ltd.

  • Divi's Laboratories Ltd.

  • Fortis Healthcare Ltd.

  • Lupin Ltd.

  • Bharti Airtel Ltd.

  • Jubilant Foodworks Ltd.

  • Ajanta Pharma Ltd.

  • Tata Motors Ltd. - DVR

  • Apollo Tyres Ltd.

  • V-Mart Retail Ltd.

  • Biocon Ltd.

  • Cash Margin - Derivatives

  • Tamil Nadu Newsprint & Papers Ltd.

  • EIH Ltd.

  • Hindustan Copper Ltd.

  • Indoco Remedies Ltd.

  • Bharti Airtel Ltd. (Right Share)

  • Andhra Paper Ltd

View More

  • Miscellaneous

  • Pharmaceuticals & Drugs

  • Consumer Food

  • Diamond & Jewellery

  • Auto Ancillary

  • Paints

  • Retailing

  • Automobiles - Passenger Cars

  • Household & Personal Products

  • Film Production, Distribution & Entertainment

  • Hospital & Healthcare Services

  • Telecommunication - Service Provider

  • Tyres & Allied

  • Paper & Paper Products

  • Hotel, Resort & Restaurants

  • Metal - Non Ferrous

View More

Fund Manager

  • Cash

  • Equity

  • Rights

  • Sov

View More

About ICICI Prudential Bharat Consumption Fund - Series 3

Scheme Analysis

ICICI Prudential Bharat Consumption Fund - Series 3 is a Equity - Sectoral Fund - Consumption fund and belongs to ICICI Prudential Mutual Fund. It was launched on 17-Jul-2018 and currently has an AUM of ₹201.38 crore. ICICI Prudential Bharat Consumption Fund - Series 3 is benchmarked against NIFTY CONSUMPTION as primary index.

The NAV of ICICI Prudential Bharat Consumption Fund - Series 3 ended down ₹-0.08(-0.47%)yesterday to ₹16.86.

Among its top 3 holdings the fund has exposure to TREPS, and

The ICICI Prudential Bharat Consumption Fund - Series 3 is managed by Priyanka Khandelwal and Anish Tawakley.

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100